SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ProMetic Life Sciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Leo Fisher who wrote (78)3/24/2017 11:36:09 AM
From: axial   of 250
 
There's no obvious sign of trouble ahead, but the stock always seems to hold a surprise or two.

This guy has offered consistent and worthwhile analysis for years -- warning of volatility, but always seeing long-term potential --



Consistent with the company's publicly-discussed NASDAQ plans at $10/shr, I'm expecting a 1-for-3 reverse split at some approaching point.
___________________________________

Structured Alpha has continued to front a lot of cash to Prometic at non-punitive -- some would say generous -- terms. From that, my inference is positive but we're still in a waiting game. Financials won't reflect the anticipated outcomes for years -- but if there's a blockbuster announcement or two in that time, Prometic's share price will stay ahead of quarterlies.

We'll see.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext